Agilent Technologies Inc. (A) is a publicly traded Healthcare sector company. As of May 21, 2026, A trades at $113.83 with a market cap of $31.68B and a P/E ratio of 24.85. A moved +2.76% today. Year to date, A is -20.39%; over the trailing twelve months it is +0.26%. Its 52-week range spans $96.43 to $160.27. Analyst consensus is strong buy with an average price target of $158.62. Rallies surfaces A's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Agilent jumps as SEC filing confirms new chief legal officer ahead of Q2 results: Agilent shares rose after a May 4, 2026 SEC filing detailed a key executive change: Michael Buckner was appointed Chief Legal Officer, replacing Bret DiMarco. The move highlighted continuity in governance ahead of Agilent’s next earnings release scheduled for May 27, 2026.
| Metric | Value |
|---|---|
| Price | $113.83 |
| Market Cap | $31.68B |
| P/E Ratio | 24.85 |
| EPS | $4.55 |
| Dividend Yield | 0.26% |
| 52-Week High | $160.27 |
| 52-Week Low | $96.43 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $7.07B |
| Net Income | $1.29B |
| Gross Margin | 52.23% |
13 analysts cover A: 0 strong buy, 12 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $158.62.